110 related articles for article (PubMed ID: 2522889)
1. Transgenic mouse models and peptide producing endocrine tumours: morpho-functional aspects.
Rindi G; Solcia E; Polak JM
Experientia Suppl; 1989; 56():210-9. PubMed ID: 2522889
[TBL] [Abstract][Full Text] [Related]
2. A morphological analysis endocrine tumour genesis in pancreas and anterior pituitary of AVP/SV40 transgenic mice.
Rindi G; Bishop AE; Murphy D; Solcia E; Hogan B; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1988; 412(3):255-66. PubMed ID: 2829418
[TBL] [Abstract][Full Text] [Related]
3. Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.
Murphy D; Bishop A; Rindi G; Murphy MN; Stamp GW; Hanson J; Polak JM; Hogan B
Am J Pathol; 1987 Dec; 129(3):552-66. PubMed ID: 2827490
[TBL] [Abstract][Full Text] [Related]
4. Morphology of adenohypophysial tumors in mice transgenic for vasopressin-SV40 hybrid oncogene.
Stefaneanu L; Rindi G; Horvath E; Murphy D; Polak JM; Kovacs K
Endocrinology; 1992 Apr; 130(4):1789-95. PubMed ID: 1312426
[TBL] [Abstract][Full Text] [Related]
5. Development of colonic and pancreatic endocrine tumours in mice expressing a glucagon-SV40 T antigen transgene.
Asa SL; Lee YC; Drucker DJ
Virchows Arch; 1996 Mar; 427(6):595-606. PubMed ID: 8605571
[TBL] [Abstract][Full Text] [Related]
6. Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice.
Messing A; Chen HY; Palmiter RD; Brinster RL
Nature; 1985 Aug 1-7; 316(6027):461-3. PubMed ID: 2991772
[TBL] [Abstract][Full Text] [Related]
7. Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.
Faas SJ; Pan S; Pinkert CA; Brinster RL; Knowles BB
J Exp Med; 1987 Feb; 165(2):417-27. PubMed ID: 3029269
[TBL] [Abstract][Full Text] [Related]
8. Multiple neuroendocrine tumours in transgenic mice induced by c-kit-SV40 T antigen fusion genes.
Bossé P; Bernex F; De Sepulveda P; Salaün P; Panthier JJ
Oncogene; 1997 Jun; 14(22):2661-70. PubMed ID: 9178764
[TBL] [Abstract][Full Text] [Related]
9. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice.
Palmiter RD; Chen HY; Messing A; Brinster RL
Nature; 1985 Aug 1-7; 316(6027):457-60. PubMed ID: 2991771
[TBL] [Abstract][Full Text] [Related]
10. Morphological study of pituitary tumorigenesis in transgenic mice induced by hybrid oncogene of the thyrotropin beta-subunit and the simian virus 40 large T-antigen.
Kon Y; Miyoshi I; Maki K; Yamashita T; Aoyama S; Watanabe T; Hayashizaki Y; Kasai N
Histol Histopathol; 1997 Oct; 12(4):981-90. PubMed ID: 9302559
[TBL] [Abstract][Full Text] [Related]
11. Expression of a fusion gene consisting of the mouse growth hormone-releasing hormone gene promoter linked to the SV40 T-antigen gene in transgenic mice.
Nogues N; Magnan E; De Grandis P; Butz M; Kineman RD; Kopchick JJ; Frohman LA
Mol Cell Endocrinol; 1998 Feb; 137(2):161-8. PubMed ID: 9605518
[TBL] [Abstract][Full Text] [Related]
12. Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.
Götz W; Schucht C; Roth J; Theuring F; Herken R
Am J Pathol; 1993 May; 142(5):1493-503. PubMed ID: 8388173
[TBL] [Abstract][Full Text] [Related]
13. Capacity of simian virus 40 T antigen to induce self-tolerance but not immunological privilege in the anterior chamber of the eye.
Ma D; Comerford S; Bellingham D; Sambrook J; Gething MJ; Alizadeh H; Anand R; Mellon J; Niederkorn JY
Transplantation; 1994 Mar; 57(5):718-25. PubMed ID: 8140635
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mouse model: a new approach for the investigation of endocrine pancreatic B-cell growth.
Power RF; Holm R; Bishop AE; Varndell IM; Alpert S; Hanahan D; Polak JM
Gut; 1987; 28 Suppl(Suppl):121-9. PubMed ID: 2826309
[TBL] [Abstract][Full Text] [Related]
15. SV40 TAg mouse models of cancer.
Colvin EK; Weir C; Ikin RJ; Hudson AL
Semin Cell Dev Biol; 2014 Mar; 27():61-73. PubMed ID: 24583142
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors.
Brinster RL; Chen HY; Messing A; van Dyke T; Levine AJ; Palmiter RD
Cell; 1984 Jun; 37(2):367-79. PubMed ID: 6327063
[TBL] [Abstract][Full Text] [Related]
17. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice.
Windle JJ; Weiner RI; Mellon PL
Mol Endocrinol; 1990 Apr; 4(4):597-603. PubMed ID: 1704103
[TBL] [Abstract][Full Text] [Related]
18. Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen.
Theuring F; Götz W; Balling R; Korf HW; Schulze F; Herken R; Gruss P
Oncogene; 1990 Feb; 5(2):225-32. PubMed ID: 2157185
[TBL] [Abstract][Full Text] [Related]
19. "Sub-threshold neoplastic states" created in transgenic mice.
Rassoulzadegan M; Cuzin F
Oncogene Res; 1987 Jun; 1(1):1-6. PubMed ID: 2835726
[TBL] [Abstract][Full Text] [Related]
20. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS
Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]